Curis, Inc.
לונג

Great partners, well oversold, FDA approved, small float, lots o

This is worth owning at $1.33. Great partners in Roche and Genentech, lots of cash (55M), small float, and small debt. Bleed rate is also very small. Great potential here with this falling wedge pattern...
CRISIBB

פרסומים קשורים

כתב ויתור